You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 7, 2024

Details for Patent: 11,020,448


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 11,020,448
Title:Methods comprising desmopressin
Abstract: The present disclosure is directed to reducing nocturnal voids by administering a dose of desmopressin over a minimum treatment period compared to before administration, and maintaining or improving the reduction of nocturnal voids over the minimum treatment period.
Inventor(s): Klein; Bjarke Mirner (Frederiksberg, DK), Norgaard; Jens Peter (Frederiksberg, DK)
Assignee: FERRING B.V. (Hoofddorp, NL)
Application Number:16/162,453
Patent Claim Types:
see list of patent claims
Use; Dosage form;

Drugs Protected by US Patent 11,020,448

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Ferring Pharms Inc NOCDURNA desmopressin acetate TABLET;SUBLINGUAL 022517-001 Jun 21, 2018 DISCN Yes No ⤷  Sign Up ⤷  Sign Up TREATMENT OF NOCTURIA DUE TO NOCTURNAL POLYURIA IN ADULTS, COMPRISING MONITORING A PATIENT'S SERUM SODIUM CONCENTRATION ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 11,020,448

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 2712622 ⤷  Sign Up PA2017001 Lithuania ⤷  Sign Up
European Patent Office 2712622 ⤷  Sign Up 122017000006 Germany ⤷  Sign Up
European Patent Office 2712622 ⤷  Sign Up LUC00015 Luxembourg ⤷  Sign Up
European Patent Office 3225249 ⤷  Sign Up 300983 Netherlands ⤷  Sign Up
European Patent Office 3225249 ⤷  Sign Up CA 2019 00023 Denmark ⤷  Sign Up
European Patent Office 3225249 ⤷  Sign Up 2019C/520 Belgium ⤷  Sign Up
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.